Enteral Feeding Formulas Market Snapshot
“From 2023 to 2030, the worldwide enteral feeding formula market is estimated to increase at a 9.1% CAGR. It is predicted to grow from USD 4.6 billion in 2023 to more than USD 9.9 billion by 2030.”
Enteral feeding formulas, also known as enteral nutrition or tube feeding formulas, are specialized liquid or powdered nutritional products designed for individuals who are unable to consume adequate nutrition orally. These formulas are administered through a feeding tube directly into the gastrointestinal tract.
Enteral feeding formulas are specially formulated to provide a balanced combination of macronutrients (carbohydrates, proteins, and fats), vitamins, minerals, and other essential nutrients. They are designed to meet the specific nutritional requirements of individuals who cannot consume a regular diet due to medical conditions or swallowing difficulties.
These formulas help ensure that patients receive the necessary nutrients to support their overall health and well-being. In situations where patients are recovering from surgery, illness, or injury, enteral feeding formulas can provide the necessary nutrients to support the healing process.
They help promote tissue repair, maintain immune function, and prevent malnutrition, which is particularly important for patients with compromised health or weakened immune systems. Enteral feeding formulas are crucial in preventing and treating malnutrition.
Malnutrition can occur in individuals with conditions such as cancer, gastrointestinal disorders, neurological disorders, or prolonged illness. Enteral feeding formulas supply adequate nutrition to prevent weight loss, muscle wasting, nutrient deficiencies, and other complications associated with malnutrition.
Enteral feeding formulas are administered directly into the gastrointestinal tract, which helps maintain the function of the digestive system. This stimulation can be beneficial for patients who have limited oral intake or impaired gastrointestinal function.
It supports the absorption of nutrients, maintains gut integrity, and prevents gastrointestinal complications. For individuals who are unable to eat or have difficulty swallowing, enteral feeding formulas provide a means to receive adequate nutrition and hydration.
This helps improve their overall quality of life by reducing discomfort, preventing hunger, and promoting energy levels. Enteral feeding formulas can be administered in various settings, including hospitals, long-term care facilities, and home-based care, allowing patients to receive nutrition support while maintaining their daily activities and routines.
Enteral feeding formulas are available in a wide range of formulations, allowing healthcare professionals to select the most appropriate formula for each patient's specific needs. Specialized formulas are available for individuals with specific medical conditions, such as diabetes, renal failure, or liver disease, ensuring that their nutritional requirements are met while considering their unique dietary restrictions and therapeutic needs.
Overall, the increasing prevalence of chronic diseases, the aging population, advancements in medical technology, expanding home-based care, and rising awareness among healthcare professionals and patients are the key factors driving the growth of the enteral feeding formula market.
>>>Download Sample Report Now:https://marketreportservice.com/request-sample/enteral-feeding-formulas-market-54619
Enteral Feeding Formulas Market Segment Analysis
The global enteral feeding formulas market is segmented based on product, stage, end user, application, and region. By product, the market is bifurcated into Standard Formula, Disease-specific, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Other Disease, Specific Formula, Peptide-based formula Other Formula.
By stage, the market is bifurcated into adults and pediatrics. By end user the market is bifurcated into Hospitals, Long Term Care facilities, Nursing Homes, Assisted Living Facilities, Home Care Agencies & Hospices. By application, the market is bifurcated into Oncology, Gastrointestinal Diseases, Neurological Disorders, Diabetes, and other application.
Based on the product Standard Formula segment dominating in the Enteral Feeding Formulas Market. Standard formulas are designed to provide a balanced combination of macronutrients (carbohydrates, proteins, and fats), vitamins, and minerals, and they are suitable for individuals with normal digestion and absorption capabilities.
Standard formulas are versatile and can be used for a variety of patient populations, including those without specific dietary restrictions or medical conditions that require specialized formulas. They are often the first choice for patients who require enteral nutrition support but do not have specific nutritional needs or restrictions.
Standard formulas have been widely used for many years and have a long history of safe and effective use. Healthcare professionals are familiar with these formulas and often prescribe them as a starting point for enteral nutrition therapy. Standard formulas are generally more cost-effective compared to specialized formulas. Since they have a broader target population, they are often produced in larger volumes, leading to economies of scale and lower manufacturing costs.
Standard formulas are readily available from various manufacturers, making them easily accessible to healthcare providers and patients. This widespread availability contributes to their dominance in the market.
Factors such as advancements in medical research, growing awareness of nutrition therapy, and the introduction of innovative formulas can influence the market dynamics and potentially shift the dominance from the standard formula segment to specialized segments in the future.
Based on the end-use industry hospital segment dominating in the Enteral Feeding Formulas Market. Hospitals typically have a high volume of patients who require enteral feeding due to various medical conditions or surgical procedures. The hospital setting encompasses a wide range of departments, including intensive care units, surgical units, and medical wards, where patients may need enteral nutrition support.
This high patient volume contributes to the dominant position of hospitals in the market. Hospitals primarily cater to acute care needs, where patients require immediate medical attention and support. In acute care settings, enteral feeding is frequently employed as a part of the overall treatment plan to ensure patients receive adequate nutrition during their hospital stay.
The need for enteral feeding formulas in these acute care settings further strengthens the dominance of hospitals in the market. Hospitals provide inpatient services, meaning patients stay within the hospital premises for an extended period. During this time, if patients are unable to consume a regular diet orally, enteral feeding formulas become an essential means of providing nutrition.
Hospitals have the necessary infrastructure, medical professionals, and facilities to administer and monitor enteral nutrition, making them the preferred setting for enteral feeding. Hospitals offer specialized medical care for patients with complex medical conditions or those requiring specialized treatments.
These patients often have specific nutritional requirements that may necessitate the use of specialized enteral feeding formulas. Hospitals have access to a wide range of enteral feeding formulas, including disease-specific formulas or formulas designed for specific patient populations, allowing them to cater to diverse patient needs.
Hospitals have a multidisciplinary team of healthcare professionals, including dietitians, doctors, nurses, and pharmacists, who collaborate to determine the most appropriate enteral feeding formula for each patient. Their expertise in nutritional assessment, formulation selection, and monitoring contributes to the dominance of the hospital segment in the market.
Enteral Feeding Formulas Market Regional Outlook
In 2022, North America accounted for the largest market in the enteral feeding formulas market. North America is known for its advanced healthcare infrastructure, including well-established hospitals, clinics, and healthcare systems. This infrastructure facilitates the use of enteral feeding formulas in various healthcare settings, such as hospitals, long-term care facilities, and home-based care.
The availability of healthcare facilities and resources contributes to the dominant position of North America in the market. North America has a relatively high prevalence of chronic diseases such as cancer, diabetes, gastrointestinal disorders, and neurological conditions. Many of these conditions require enteral nutrition support as a part of the overall treatment plan.
The significant patient poplation with chronic diseases increases the demand for enteral feeding formulas in the region. North America has a significant aging population, with a large number of older adults who may require enteral feeding due to age-related conditions or illnesses.
Aging is often associated with an increased risk of swallowing difficulties, malnutrition, and other health issues that necessitate enteral nutrition support. The aging population in North America contributes to the dominant position of the region in the market.
Enteral Feeding Formulas Market Key Competitors
The Enteral Feeding Formulas Market Key Competitors Include Abbott, Nestlé, Danone S.A., Fresenius Kabi, B. Braun Melsungen Ag, Otsuka Holdings Co., Ltd., Nutritional Medicinals, Llc, Kate Farms, Medtrition Inc., Victus, Inc, Global Health Products Inc, Meiji Holdings, Reckitt Benckiser Group.
New Developments
August 11, 2023, Fresenius Kabi, NEW Label Design for Enteral Nutrition Products
Introducing our NEW label design
Enhancing readability with a fresh, contemporary design
We are pleased to inform you that from August 2023 onwards, the labels of all Fresenius Kabi tube feeds and oral nutritional supplements will be changing. This means you will notice a different look to the design of the label as well as minor changes to the wording on the label.
February 2022, Orgain, a pioneer in plant-based nutrition, and Nestlé (Switzerland) have a deal in place for Nestlé to acquire the majority of Orgain's stock in February 2022. This acquisition would improve the nutrition products that Nestlé Health Science already offers.
In September 2021, Abbott (US) launched enteral formulations for tube feeding that used organic dietary components and plant-based proteins.
Segments Covered in the Enteral Feeding Formulas Market
Enteral Feeding Formulas Market by Product
- Standard Formula
- Disease specific
- Diabetic Formula
- Renal Formula
- Hepatic Formula
- Pulmonary Formula
- Other Disease Specific Formula
- Peptide-based formula
- Other Formula
Enteral Feeding Formulas Market by Stage
Enteral Feeding Formulas Market by End-User
- Hospitals
- Long Term Care facilities
- Nursing Homes
- Assisted Living Facilities
- Home Care Agencies & Hospices
Enteral Feeding Formulas Market by Application
- Oncology
- Gastrointestinal Diseases
- Neurological Disorders
- Diabetes
- Other Applications
The above information has been provided for the following regions and countries
North America
Europe
- UK
- Germany
- France
- Italy
- Russia
Asia Pacific
- China
- India
- Japan
- South Korea
Latin America
MEA
- UAE
- Saudi Arabia
- South Africa
Frequently Asked Questions
What is the worth of the global enteral feeding formulas market?
From 2023 to 2030, the worldwide enteral feeding formula market is estimated to increase at a 9.1% CAGR. It is predicted to grow from USD 4.6 billion in 2023 to more than USD 9.9 billion by 2030.
What is the size of North America in the enteral feeding formulas industry?
North America accounted for the largest market in the Enteral Feeding Formulas market. North America held more than 38% of the enteral feeding formulas market revenue share in 2022.
What is the prime factor to drive the global enteral feeding formulas market ahead?
The prime factor driving the enteral feeding formulas market ahead is the Increasing demand for enteral feeding in-home care.
What are the opportunities in the enteral feeding formulas market?
Development of new products and innovation this factor will create more opportunities in the enteral feeding formulas market.
1.Summary
1.1. Enteral Feeding Formulas Market Overview
1.2. Key Insights
1.3. Report Scope
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
- Decision-Making Summary
- Introduction
3.1. Overview Of Enteral Feeding Formulas
3.2. Key Historical Events
3.3. Structure
3.4. Biochemical Interaction
3.5. Target Indications
3.6. Advantages Of Enteral Feeding Formulas
3.7 Challenges Associated With Enteral Feeding Formulas
3.8. Future Perspectives.
- Market Landscape
4.1. Methodology
4.2 Enteral Feeding Formulas: Developer Landscape
4.2.1. Analysis by Year Of Establishment
4.2.2. Analysis By Company Size
4.2.3. Analysis By Location Of Headquarters (Region-Wise)
4.2.4. Analysis By Location Of Headquarters (Country-Wise)
4.2.5. Analysis By Year Of Establishment, Company Size And Location Of Headquarters (Region-Wise)
4.2.6. Most Active Players
- Company
5.1. Company Overview
5.1.2 Management Team
5.1.3. Product Portfolio
5.1.4. Recent Developments And Future Outlook
- Partnerships And Collaborations
6.1. Partnership Models
6.2. Enteral Feeding Formulas: Partnerships And Collaborations
6.2.1. Analysis By Year Of Partnership
6.2.2. Analysis By Type Of Partnership
6.2.3. Analysis By Year And Type Of Partnership
6.2.4. Analysis By Type Of Partner
6.2.5. Analysis by Year Of Partnership And Type Of Partner
6.2.6. Analysis By Type Of Partnership And Type Of Partner
6.2.7. Analysis By Type Of Partner And Parent Company Size
- Academic Grants Analysis
7.1. Methodology And Key Parameters
7.2. Enteral Feeding Formulas: Academic Grants Analysis
7.2.1. Analysis By Year Of Grant Award
7.2.2. Analysis By Amount Awarded
7.2.3. Analysis By Funding Institute Center
7.2.4. Analysis By Support Period
7.2.5. Analysis By Funding Institute Center And Support Period
7.2.6. Analysis by Type Of Grant Application
7.2.7. Analysis By Purpose Of Grant
- Publication Analysis
8.1. Analysis Methodology And Key Parameters
8.2. Enteral Feeding Formulas: Publication Analysis
8.2.1. Analysis by Year Of Publication
8.2.2. Analysis By Type Of Publication
8.2.3. Analysis by Type Of Conjugate
8.2.4. Analysis by Target Indication
8.2.5. Analysis by Copyright Holder
8.2.6. Word Cloud: Emerging Focus Area
8.2.7. Most Active Publishers: Analysis By Number Of Publications
- Success Protocol Analysis
9.1. Methodology and Key Parameters
9.2. Key Assumptions and Scoring Criteria
9.3. Success Protocol Analysis
9.4. Assessment of Approved Enteral Feeding Formulas
- Appendix 1: Tabulated Data
- Appendix 2: List Of Companies
- Abbott
- Nestlé
- Danone S.A.
- Fresenius Kabi
- Braun Melsungen Ag
- Otsuka Holdings Co.
- Nutritional Medicinals
- Kate Farms
- Medtrition Inc.
- Victus
- Global Health Products Inc
- Meiji Holdings
- Reckitt Benckiser Group
